How do we define recurrence in Clostridium difficile infection?

Bradley, C W; Burdett, H; Holden, K L; Holden, E; Garvey, M I

Bradley, C W; Burdett, H; Holden, K L; Holden, E; Garvey, M I.

Afiliación

Bradley CW; Gloucestershire Hospitals NHS Foundation Trust, Gloucestershire Royal Hospital, Gloucester, UK.
Burdett H; University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham, UK.
Holden KL; University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham, UK.
Holden E; University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham, UK.
Garvey MI; Gloucestershire Hospitals NHS Foundation Trust, Gloucestershire Royal Hospital, Gloucester, UK; University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham, UK; Institute of Microbiology and Infection, The University of Birmingham, Edgbaston, Birm

J Hosp Infect ; 102(2): 171-173, 2019 06.

Article en En | MEDLINE | ID: mdl-30055221

Asunto(s)

Clostridioides difficile; Infecciones por Clostridium; Fidaxomicina; Humanos; Recurrencia; Centros de Atención Terciaria; Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Clostridioides difficile / Infecciones por Clostridium Límite: Humans País/Región como asunto: Europa Idioma: En Revista: J Hosp Infect Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google